Visual acuity suppression: Difference between revisions

Line 3:

'''Acuity suppression''' can be described as the experience of a person's sense of vision becoming partially to completely blurred and indistinct. <ref>Hollister L. E. (1984). Effects of hallucinogens in humans,” in Hallucinogens: Neurochemical, Behavioral and Clinical Perspectives, ed Jacobs B. L., editor. (New York, NY: Raven Press; ), 19–33.</ref><ref>Masters R. E. L. (1966). The Varieties of Psychedelic Experience. New York, NY: Henry Holt & Company, Inc.</ref><ref>Nichols D. E. (2004). Hallucinogens. Pharmacol. Ther. 101, 131–181. https://doi.org/10.1016/j.pharmthera.2003.11.002</ref><ref>Gallimore, A. R. (2015). Restructuring consciousness–the psychedelic state in light of integrated information theory. Frontiers in human neuroscience, 9, 346. https://dx.doi.org/10.3389%2Ffnhum.2015.00346</ref> This effect may affect the entirety of the person's vision or specific sections of it. Depending on its intensity, this can often result in a reduced ability to function and perform basic tasks which necessitate the use of sight.

Acuity suppression is often accompanied by other coinciding effects such as [[double vision]] and [[pattern recognition suppression]]. This effect is most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of [[depressant]] and [[dissociative]] compounds, such as [[alcohol]], [[quetiapine]], [[ketamine]], and [[DXM]].

Acuity suppression is often accompanied by other coinciding effects such as [[double vision]]<ref>Smith, J. L., & Buncic, J. R. (1999). Drugs which can affect near vision: a useful list. American Orthoptic Journal, 49, 180-190. https://uwpress.wisc.edu/journals/pdfs/AOJ_49_178.pdf</ref> and [[pattern recognition suppression]]. This effect is most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of [[depressant]] and [[dissociative]] compounds, such as [[alcohol]], [[quetiapine]], [[ketamine]], and [[DXM]].

</onlyinclude>

===Psychoactive substances===

@@ Line 3: / Line 3: @@
 '''Acuity suppression''' can be described as the experience of a person's sense of vision becoming partially to completely blurred and indistinct. <ref>Hollister L. E. (1984). Effects of hallucinogens in humans,” in Hallucinogens: Neurochemical, Behavioral and Clinical Perspectives, ed Jacobs B. L., editor. (New York, NY: Raven Press; ), 19–33.</ref><ref>Masters R. E. L. (1966). The Varieties of Psychedelic Experience. New York, NY: Henry Holt & Company, Inc.</ref><ref>Nichols D. E. (2004). Hallucinogens. Pharmacol. Ther. 101, 131–181. https://doi.org/10.1016/j.pharmthera.2003.11.002</ref><ref>Gallimore, A. R. (2015). Restructuring consciousness–the psychedelic state in light of integrated information theory. Frontiers in human neuroscience, 9, 346. https://dx.doi.org/10.3389%2Ffnhum.2015.00346</ref> This effect may affect the entirety of the person's vision or specific sections of it. Depending on its intensity, this can often result in a reduced ability to function and perform basic tasks which necessitate the use of sight.
-Acuity suppression is often accompanied by other coinciding effects such as [[double vision]] and [[pattern recognition suppression]]. This effect is most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of [[depressant]] and [[dissociative]] compounds, such as [[alcohol]], [[quetiapine]], [[ketamine]], and [[DXM]].
+Acuity suppression is often accompanied by other coinciding effects such as [[double vision]]<ref>Smith, J. L., & Buncic, J. R. (1999). Drugs which can affect near vision: a useful list. American Orthoptic Journal, 49, 180-190. https://uwpress.wisc.edu/journals/pdfs/AOJ_49_178.pdf</ref> and [[pattern recognition suppression]]. This effect is most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of [[depressant]] and [[dissociative]] compounds, such as [[alcohol]], [[quetiapine]], [[ketamine]], and [[DXM]].
 </onlyinclude>
 ===Psychoactive substances===